Liraglutide and Peripheral Artery Disease
NCT04881110
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Peripheral Arterial Disease
Interventions
DRUG:
Liraglutide
OTHER:
Control
Sponsor
University of Campania Luigi Vanvitelli